GLP-IR modulating compounds

A method of treating a GLP-1R mediated disease or condition in a subject in need thereof comprising administering to the subject a pharmaceutically effective amount of a compound of Formula (II):

• or a pharmaceutically acceptable salt thereof, wherein
• R1 is a phenyl or 6 membered heteroaryl optionally substituted with 1, 2, or 3 R4;
• X1 is —C(H)═ or —C(R8)═;
• X4 is —C(H)═, —C(R8)═ or N;
• each R4 is independently halogen or —CN;
• each RB is independently C1-9 alkyl, C1-8 haloalkyl, or halogen;
• each R8 is independently halogen;
• and
• n is 0, 1, 2, or 3.